F15.188
Other stimulant abuse with other stimulant-induced disorder
Clinical Classification Guidelines
Inclusion Terms
- Amphetamine or other stimulant use disorder, mild, with amphetamine or other stimulant induced obsessive-compulsive or related disorder
Medical Intelligence & Overview
The ICD-10 code F15.188 refers to a condition involving the abuse of stimulants, such as amphetamines, combined with a stimulant-induced obsessive-compulsive or related disorder. This diagnosis indicates that a person has a pattern of harmful stimulant use that has led to specific behavioral or mental health issues caused directly by the stimulant's effects on the brain. Typically classified as mild, this condition highlights the complex relationship between substance abuse and mental health, emphasizing the need for comprehensive understanding and management.
Causes & Symptoms
Clinical Causes: Repeated use of stimulants like amphetamines, methamphetamines, or other related substances Genetic predisposition influencing susceptibility to substance abuse Environmental factors including peer influence, stress, and availability of substances Underlying mental health conditions that may contribute to the initiation of stimulant use Habitual or recreational use escalating into dependence
Key Symptoms: Obsessive thoughts or compulsive behaviors related to stimulant use Persistent craving or urge to consume stimulants Restlessness or heightened energy levels Difficulty concentrating or maintaining focus Altered sleep patterns, such as insomnia or hypersomnia Irritability or mood swings Physical signs like increased heart rate or blood pressure Potential development of paranoid thoughts or hallucinations in more severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive assessment by a healthcare professional, including a detailed medical history and substance use evaluation. Healthcare providers may use standardized questionnaires to identify stimulant use disorder and observe symptoms indicative of stimulant-induced obsessive-compulsive behaviors. Laboratory tests, such as urine drug screens, can confirm recent stimulant use. The clinician will determine if the person meets criteria for a mild stimulant use disorder and if the symptoms align with stimulant-induced obsessive-compulsive or related disorders.
Treatment Protocols: Treatment typically includes a combination of approaches tailored to individual needs. These may involve: - Behavioral therapies, such as cognitive-behavioral therapy (CBT), to address substance use and obsessive-compulsive symptoms - Counseling and psychosocial support to understand triggers and develop coping strategies - Pharmacological interventions in some cases to manage symptoms or co-occurring mental health issues - Support groups or outpatient programs to provide ongoing assistance and accountability Successful management aims to reduce stimulant use, alleviate obsessive-compulsive symptoms, and address underlying mental health conditions, promoting recovery and improving quality of life.
Clinical Advice & FAQs
Billing Guidance
Is F15.188 a billable ICD-10 code?
Yes, F15.188 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F15.188?
Clinical documentation must specify the nature of Other stimulant abuse with other stimulant-induced disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference